Arcutis Launches ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Children Ages 2 to 5

Once-daily, effective, safe, and well-tolerated ZORYVE cream 0.05% now commercially available for children as young as age 2ZORYVE cream 0.05% ...
The American Journal of Managed Care

Non-Ssteroidal Topical Therapies for Pediatric Atopic Dermatitis: Reducing Corticosteroid Dependence and Biologic Escalation

Experts discuss the impact of severe eczema on children’s daily lives and the role of newer non-steroidal topical therapies ...
Healthline

Side Effects of Prolia: What You Need to Know

Prolia (denosumab) can cause side effects that range from mild to serious. Examples include joint pain and tooth and jaw-related side effects. If side effects from Prolia become difficult to tolerate, ...